Search Results Search Sort by RelevanceMost Recent Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345. Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472. Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725. Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.
Case and Commentary May 2022 Should Clinicians Ever Recommend Supplements to Patients Trying to Lose Weight? Melinda M. Manore, PhD, RDN and Megan Patton-Lopez, PhD, RDN Helping patients mitigate their risk of chronic disease is key, but dietary supplements are risky. AMA J Ethics. 2022;24(5):E345-352. doi: 10.1001/amajethics.2022.345.
Case and Commentary Jul 2023 Why We Need to Stop Labeling Behaviors Influencing a Person’s Weight Ideal or Healthy Madeline Ward, PhD Healthist views about body shape and weight are oppressive and lead to pernicious harms, especially to members of vulnerable groups. AMA J Ethics. 2023;25(7):E472-477. doi: 10.1001/amajethics.2023.472.
Case and Commentary Oct 2023 Should Antipsychotics’ Risks Be Accepted by Clinicians on Behalf of Patients to Achieve Benefits of Mitigating Older Adults’ Behavioral Symptoms in Short-Staffed Units? Alex Rollo, MD, Jeena Kar, DO, Uma Suryadevara, MD, and Mary Camp, MD This commentary considers how to manage agitation in patients with dementia. AMA J Ethics. 2023;25(10):E725-732. doi: 10.1001/amajethics.2023.725.
Medicine and Society Oct 2023 Prioritizing Diversion and Decarceration of People With Dementia Lay Kodama, MD, PhD, Brie Williams, MD, MS, and Nathaniel P. Morris, MD An aging prison population means more people who are incarcerated will experience dementia and related symptoms. AMA J Ethics. 2023;25(10):E783-790. doi: 10.1001/amajethics.2023.783.